|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 14/54 | (2006.01) |
| C12N 15/24 | (2006.01) | ||
| C12N 15/62 | (2006.01) |
| (11) | Number of the document | 3265478 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16708154.6 |
| Date of filing the European patent application | 2016-03-07 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (86) | Number | PCT/EP2016/054729 |
| Date | 2016-03-07 |
| (87) | Number | WO 2016/142314 |
| Date | 2016-09-15 |
| (30) | Number | Date | Country code |
| 15157911 | 2015-03-06 | EP |
| (72) |
GUNDRAM, Jung, DE
SALIH, Helmut, DE
LINDNER, Cornelia, DE
LOCHMANN, Berit, DE
|
| (73) |
DKFZ Deutsches Krebsforschungszentrum,
Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280, 69120 Heidelberg,
DE
Eberhard Karls Universität Tübingen, Medizinische Fakultät Geschwister-Scholl-Platz, 72074 Tübingen, DE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Sulieti baltymai, apimantys surišantį baltymą ir interleukino-15 polipeptidą, kuriam būdingas sumažintas giminingumas IL-15Ra, ir jų terapinis panaudojimas |
| FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15RA AND THERAPEUTIC USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-02-23 | 8 | 185.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-12-12 |